<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Bartter_syndrome</id>
	<title>Bartter syndrome - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Bartter_syndrome"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Bartter_syndrome&amp;action=history"/>
	<updated>2026-04-17T16:41:07Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=389293&amp;oldid=prev</id>
		<title>Danbot: Strip excess bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=389293&amp;oldid=prev"/>
		<updated>2026-03-22T09:31:53Z</updated>

		<summary type="html">&lt;p&gt;Strip excess bold&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:31, 22 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot;&gt;Line 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*The critical EM task is to recognize the electrolyte pattern, correct life-threatening hypokalemia, and avoid attributing the findings to vomiting or diuretic abuse.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*The critical EM task is to recognize the electrolyte pattern, correct life-threatening hypokalemia, and avoid attributing the findings to vomiting or diuretic abuse.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Incidence ~1 in 1,000,000; much rarer than [[Gitelman syndrome]] (~1 in 25,000)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Incidence ~1 in 1,000,000; much rarer than [[Gitelman syndrome]] (~1 in 25,000)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Neonatal/antenatal Bartter:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;severe; presents in utero with polyhydramnios → premature birth → massive polyuria, dehydration, nephrocalcinosis within first weeks of life&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Neonatal/antenatal Bartter: severe; presents in utero with polyhydramnios → premature birth → massive polyuria, dehydration, nephrocalcinosis within first weeks of life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Classic Bartter:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;presents in infancy to school age with polyuria, polydipsia, failure to thrive, growth retardation&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Classic Bartter: presents in infancy to school age with polyuria, polydipsia, failure to thrive, growth retardation&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Biochemically mimics '''chronic furosemide use''' — the transporter affected (NKCC2) is the same target as loop diuretics&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Biochemically mimics '''chronic furosemide use''' — the transporter affected (NKCC2) is the same target as loop diuretics&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*'''Pseudo-Bartter syndrome''' can occur in cystic fibrosis (salt loss in sweat), chronic vomiting, or diuretic abuse — must be excluded&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*'''Pseudo-Bartter syndrome''' can occur in cystic fibrosis (salt loss in sweat), chronic vomiting, or diuretic abuse — must be excluded&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l18&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Cardiac arrhythmias — potentially fatal; from severe hypokalemia ± hypomagnesemia; '''cardiac arrest has been reported'''&amp;lt;ref name=&amp;quot;ERKNet&amp;quot;&amp;gt;Konrad M, et al. Diagnosis and management of Bartter syndrome: consensus from ERKNet. ''Kidney Int''. 2021;99(2):324-338.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Cardiac arrhythmias — potentially fatal; from severe hypokalemia ± hypomagnesemia; '''cardiac arrest has been reported'''&amp;lt;ref name=&amp;quot;ERKNet&amp;quot;&amp;gt;Konrad M, et al. Diagnosis and management of Bartter syndrome: consensus from ERKNet. ''Kidney Int''. 2021;99(2):324-338.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Normal or low blood pressure despite high renin/aldosterone (distinguishes from other causes of hyperaldosteronism)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Normal or low blood pressure despite high renin/aldosterone (distinguishes from other causes of hyperaldosteronism)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Neonatal Bartter: history of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;polyhydramnios and premature birth&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Neonatal Bartter: history of polyhydramnios and premature birth&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Some subtypes: &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;sensorineural deafness&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(type IV)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Some subtypes: sensorineural deafness (type IV)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Dysmorphic facies in some neonatal cases: triangular face, protruding ears, large eyes&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Dysmorphic facies in some neonatal cases: triangular face, protruding ears, large eyes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Differential Diagnosis==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Differential Diagnosis==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Gitelman syndrome]]: the most important differential — milder, presents later (adolescence/adulthood), has &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;hypocalciuria and hypomagnesemia&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(Bartter has &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;hypercalciuria&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;and usually normal magnesium); mimics &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;thiazide diuretic&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;use rather than loop diuretic use&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Gitelman syndrome]]: the most important differential — milder, presents later (adolescence/adulthood), has hypocalciuria and hypomagnesemia (Bartter has hypercalciuria and usually normal magnesium); mimics thiazide diuretic use rather than loop diuretic use&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l40&quot;&gt;Line 40:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Surreptitious vomiting / bulimia: urine chloride &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&amp;lt;25 mEq/L&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(Bartter: &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;urine chloride &amp;gt;35 mEq/L&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;) — this is the key distinguishing test&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Surreptitious vomiting / bulimia: urine chloride &amp;lt;25 mEq/L (Bartter: urine chloride &amp;gt;35 mEq/L) — this is the key distinguishing test&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Diuretic abuse: screen urine for diuretics&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Diuretic abuse: screen urine for diuretics&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Congenital adrenal hyperplasia (neonatal salt-wasting form) — hyperkalemia with salt wasting (opposite potassium direction from Bartter)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Congenital adrenal hyperplasia (neonatal salt-wasting form) — hyperkalemia with salt wasting (opposite potassium direction from Bartter)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l60&quot;&gt;Line 60:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 60:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine potassium elevated — inappropriate renal potassium wasting&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine potassium elevated — inappropriate renal potassium wasting&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine calcium:creatinine ratio elevated — hypercalciuria (classic Bartter); LOW in Gitelman&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine calcium:creatinine ratio elevated — hypercalciuria (classic Bartter); LOW in Gitelman&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Renin and aldosterone: both elevated (secondary hyperaldosteronism) — but blood pressure is &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;not&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;elevated&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Renin and aldosterone: both elevated (secondary hyperaldosteronism) — but blood pressure is not elevated&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*ECG: assess for hypokalemia changes (flattened T waves, U waves, ST depression, prolonged QT, arrhythmias)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*ECG: assess for hypokalemia changes (flattened T waves, U waves, ST depression, prolonged QT, arrhythmias)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Renal ultrasound: nephrocalcinosis (especially neonatal Bartter types I and II)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Renal ultrasound: nephrocalcinosis (especially neonatal Bartter types I and II)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l71&quot;&gt;Line 71:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 71:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Management==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Management==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Correct hypokalemia — this is the EM priority&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Correct hypokalemia — this is the EM priority&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**IV potassium chloride for severe hypokalemia (K &amp;lt;2.5 mEq/L) or ECG changes or arrhythmias — &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;use KCl, not other potassium salts&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(the chloride is needed to correct the concurrent hypochloremia and alkalosis)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**IV potassium chloride for severe hypokalemia (K &amp;lt;2.5 mEq/L) or ECG changes or arrhythmias — use KCl, not other potassium salts (the chloride is needed to correct the concurrent hypochloremia and alkalosis)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oral potassium supplementation for mild-moderate hypokalemia&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oral potassium supplementation for mild-moderate hypokalemia&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Potassium replacement may be massive — these patients have ongoing renal losses; expect to give more than typical and monitor closely&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Potassium replacement may be massive — these patients have ongoing renal losses; expect to give more than typical and monitor closely&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Correct hypomagnesemia if present (magnesium deficiency causes refractory hypokalemia)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Correct hypomagnesemia if present (magnesium deficiency causes refractory hypokalemia)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Aggressive IV fluid resuscitation with &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;normal saline&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;for dehydration — these patients are volume-depleted from renal salt wasting&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Aggressive IV fluid resuscitation with normal saline for dehydration — these patients are volume-depleted from renal salt wasting&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Cardiac monitoring — continuous telemetry if K &amp;lt;3.0 mEq/L or any ECG changes&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Cardiac monitoring — continuous telemetry if K &amp;lt;3.0 mEq/L or any ECG changes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Continue home medications if the patient takes indomethacin, potassium supplements, or spironolactone — '''do NOT discontinue these'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Continue home medications if the patient takes indomethacin, potassium supplements, or spironolactone — '''do NOT discontinue these'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l94&quot;&gt;Line 94:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 94:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Stable hemodynamics&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Stable hemodynamics&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Pediatric nephrology follow-up within days&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Pediatric nephrology follow-up within days&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*New diagnosis suspected (unexplained hypokalemic metabolic alkalosis in a young patient with renal potassium/chloride wasting and normal BP): arrange &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;nephrology referral&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;for confirmatory workup&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*New diagnosis suspected (unexplained hypokalemic metabolic alkalosis in a young patient with renal potassium/chloride wasting and normal BP): arrange nephrology referral for confirmatory workup&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Counsel families: aggressive oral hydration is critical (especially during illness, hot weather, exercise); report symptoms of hypokalemia (weakness, cramps, palpitations, fainting) immediately&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Counsel families: aggressive oral hydration is critical (especially during illness, hot weather, exercise); report symptoms of hypokalemia (weakness, cramps, palpitations, fainting) immediately&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=386192&amp;oldid=prev</id>
		<title>Danbot: Moved intro to Background bullets; removed excessive bold; added DDX template transclusions</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=386192&amp;oldid=prev"/>
		<updated>2026-03-19T12:08:23Z</updated>

		<summary type="html">&lt;p&gt;Moved intro to Background bullets; removed excessive bold; added DDX template transclusions&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Bartter_syndrome&amp;amp;diff=386192&amp;amp;oldid=386173&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=386173&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;Bartter syndrome is a group of rare autosomal recessive renal tubular disorders causing '''salt wasting from the thick ascending limb of the loop of Henle''', resulting in '''hypokalemic hypochloremic metabolic alkalosis''' with '''normal or low blood pressure'''.&lt;ref name=&quot;StatPearls&quot;&gt;Bartter Syndrome. ''StatPearls''. NCBI. 2026.&lt;/ref&gt; It mimics '''chronic loop diuretic use'''. The EM physician encounters Bartter syndrome as a '''severely dehydrated infant with refracto...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Bartter_syndrome&amp;diff=386173&amp;oldid=prev"/>
		<updated>2026-03-18T02:41:44Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Bartter syndrome is a group of rare autosomal recessive renal tubular disorders causing &amp;#039;&amp;#039;&amp;#039;salt wasting from the thick ascending limb of the loop of Henle&amp;#039;&amp;#039;&amp;#039;, resulting in &amp;#039;&amp;#039;&amp;#039;hypokalemic hypochloremic metabolic alkalosis&amp;#039;&amp;#039;&amp;#039; with &amp;#039;&amp;#039;&amp;#039;normal or low blood pressure&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Bartter Syndrome. &amp;#039;&amp;#039;StatPearls&amp;#039;&amp;#039;. NCBI. 2026.&amp;lt;/ref&amp;gt; It mimics &amp;#039;&amp;#039;&amp;#039;chronic loop diuretic use&amp;#039;&amp;#039;&amp;#039;. The EM physician encounters Bartter syndrome as a &amp;#039;&amp;#039;&amp;#039;severely dehydrated infant with refracto...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Bartter syndrome is a group of rare autosomal recessive renal tubular disorders causing '''salt wasting from the thick ascending limb of the loop of Henle''', resulting in '''hypokalemic hypochloremic metabolic alkalosis''' with '''normal or low blood pressure'''.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Bartter Syndrome. ''StatPearls''. NCBI. 2026.&amp;lt;/ref&amp;gt; It mimics '''chronic loop diuretic use'''. The EM physician encounters Bartter syndrome as a '''severely dehydrated infant with refractory hypokalemia''', a '''child with failure to thrive and electrolyte derangements''', or a '''known patient in crisis''' from intercurrent illness. The critical EM task is to '''recognize the electrolyte pattern, correct life-threatening hypokalemia, and avoid attributing the findings to vomiting or diuretic abuse'''.&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*Incidence ~1 in 1,000,000; much rarer than [[Gitelman syndrome]] (~1 in 25,000)&lt;br /&gt;
*'''Neonatal/antenatal Bartter:''' severe; presents in utero with polyhydramnios → premature birth → massive polyuria, dehydration, nephrocalcinosis within first weeks of life&lt;br /&gt;
*'''Classic Bartter:''' presents in infancy to school age with polyuria, polydipsia, failure to thrive, growth retardation&lt;br /&gt;
*Biochemically mimics '''chronic furosemide use''' — the transporter affected (NKCC2) is the same target as loop diuretics&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Pseudo-Bartter syndrome''' can occur in cystic fibrosis (salt loss in sweat), chronic vomiting, or diuretic abuse — must be excluded&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*'''Polyuria and polydipsia''' (often severe; neonates may lose &amp;gt;10% body weight in first days)&lt;br /&gt;
*'''Dehydration''' — may be profound, especially with intercurrent illness (vomiting, diarrhea, fever)&lt;br /&gt;
*'''Failure to thrive, growth retardation'''&lt;br /&gt;
*'''Muscle weakness, cramps, fatigue''' (from hypokalemia)&lt;br /&gt;
*'''Constipation''' (from hypokalemia)&lt;br /&gt;
*'''Cardiac arrhythmias''' — potentially fatal; from severe hypokalemia ± hypomagnesemia; '''cardiac arrest has been reported'''&amp;lt;ref name=&amp;quot;ERKNet&amp;quot;&amp;gt;Konrad M, et al. Diagnosis and management of Bartter syndrome: consensus from ERKNet. ''Kidney Int''. 2021;99(2):324-338.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*'''Normal or low blood pressure''' despite high renin/aldosterone (distinguishes from other causes of hyperaldosteronism)&lt;br /&gt;
*Neonatal Bartter: history of '''polyhydramnios and premature birth'''&lt;br /&gt;
*Some subtypes: '''sensorineural deafness''' (type IV)&lt;br /&gt;
*'''Dysmorphic facies''' in some neonatal cases: triangular face, protruding ears, large eyes&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
*'''[[Gitelman syndrome]]:''' the most important differential — milder, presents later (adolescence/adulthood), has '''hypocalciuria and hypomagnesemia''' (Bartter has '''hypercalciuria''' and usually normal magnesium); mimics '''thiazide diuretic''' use rather than loop diuretic use&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Feature !! '''Bartter syndrome''' !! '''[[Gitelman syndrome]]'''&lt;br /&gt;
|-&lt;br /&gt;
| Mimics || '''Loop diuretic''' (furosemide) || '''Thiazide diuretic''' (HCTZ)&lt;br /&gt;
|-&lt;br /&gt;
| Onset || Infancy/childhood (often neonatal) || Adolescence/adulthood&lt;br /&gt;
|-&lt;br /&gt;
| Severity || More severe; life-threatening dehydration || Milder; often incidental finding&lt;br /&gt;
|-&lt;br /&gt;
| Urine calcium || '''High''' (hypercalciuria → nephrocalcinosis) || '''Low''' (hypocalciuria)&lt;br /&gt;
|-&lt;br /&gt;
| Magnesium || Usually normal || '''Low''' (hypomagnesemia)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
*'''Surreptitious vomiting / bulimia:''' urine chloride '''&amp;lt;25 mEq/L''' (Bartter: '''urine chloride &amp;gt;35 mEq/L''') — this is the key distinguishing test&lt;br /&gt;
*'''Diuretic abuse:''' screen urine for diuretics&lt;br /&gt;
*'''Congenital adrenal hyperplasia''' (neonatal salt-wasting form) — hyperkalemia with salt wasting (opposite potassium direction from Bartter)&lt;br /&gt;
*'''Cystic fibrosis''' (pseudo-Bartter from sweat salt loss) — sweat chloride test&lt;br /&gt;
*'''Chronic laxative abuse'''&lt;br /&gt;
*'''Primary hyperaldosteronism''' — hypertension present (Bartter is normotensive/hypotensive)&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===Workup===&lt;br /&gt;
*'''BMP:''' '''hypokalemia''' (may be severe, &amp;lt;2.5 mEq/L), '''hypochloremia''', '''metabolic alkalosis''' (elevated bicarbonate), normal or low sodium&lt;br /&gt;
*'''Magnesium:''' normal in most Bartter (low suggests Gitelman or type III Bartter)&lt;br /&gt;
*'''ABG/VBG:''' metabolic alkalosis&lt;br /&gt;
*'''Urine electrolytes:'''&lt;br /&gt;
**'''Urine chloride &amp;gt;35 mEq/L''' — confirms renal salt wasting (NOT vomiting)&lt;br /&gt;
**'''Urine potassium elevated''' — inappropriate renal potassium wasting&lt;br /&gt;
**'''Urine calcium:creatinine ratio elevated''' — hypercalciuria (classic Bartter); LOW in Gitelman&lt;br /&gt;
*'''Renin and aldosterone:''' both elevated (secondary hyperaldosteronism) — but blood pressure is '''not''' elevated&lt;br /&gt;
*'''ECG:''' assess for hypokalemia changes (flattened T waves, U waves, ST depression, prolonged QT, arrhythmias)&lt;br /&gt;
*'''Renal ultrasound:''' nephrocalcinosis (especially neonatal Bartter types I and II)&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
*'''Hypokalemic hypochloremic metabolic alkalosis + elevated urine chloride (&amp;gt;35) + normal/low blood pressure + elevated renin/aldosterone''' = Bartter syndrome pattern&lt;br /&gt;
*Exclude vomiting (urine Cl &amp;lt;25), diuretic abuse (urine drug screen), and laxative abuse&lt;br /&gt;
*Genetic testing (SLC12A1, KCNJ1, CLCNKB, BSND, CASR) confirms subtype — not an ED test&lt;br /&gt;
*'''The diagnosis is clinical and biochemical''' — genetic confirmation follows&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
*'''Correct hypokalemia — this is the EM priority'''&lt;br /&gt;
**'''IV potassium chloride''' for severe hypokalemia (K &amp;lt;2.5 mEq/L) or ECG changes or arrhythmias — '''use KCl, not other potassium salts''' (the chloride is needed to correct the concurrent hypochloremia and alkalosis)&lt;br /&gt;
**'''Oral potassium supplementation''' for mild-moderate hypokalemia&lt;br /&gt;
**'''Potassium replacement may be massive''' — these patients have ongoing renal losses; expect to give more than typical and monitor closely&lt;br /&gt;
**'''Correct hypomagnesemia''' if present (magnesium deficiency causes refractory hypokalemia)&lt;br /&gt;
*'''Aggressive IV fluid resuscitation''' with '''normal saline''' for dehydration — these patients are volume-depleted from renal salt wasting&lt;br /&gt;
*'''Cardiac monitoring''' — continuous telemetry if K &amp;lt;3.0 mEq/L or any ECG changes&lt;br /&gt;
*'''Continue home medications''' if the patient takes indomethacin, potassium supplements, or spironolactone — '''do NOT discontinue these'''&lt;br /&gt;
*'''Treat precipitating illness:''' intercurrent infection, GI illness, or any condition that worsens salt/water losses can precipitate acute crisis&lt;br /&gt;
*'''Do NOT use loop diuretics''' (furosemide) — this worsens the underlying defect&lt;br /&gt;
*'''Perioperative alert:''' patients with Bartter syndrome require careful electrolyte monitoring and IV potassium during surgery/anesthesia; alert anesthesia team if the patient presents for a procedure&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''Admit:'''&lt;br /&gt;
**Severe hypokalemia (K &amp;lt;2.5 mEq/L) or ECG changes/arrhythmias&lt;br /&gt;
**Severe dehydration requiring IV resuscitation&lt;br /&gt;
**Neonatal presentation (needs NICU; nephrology consultation)&lt;br /&gt;
**Unable to tolerate oral fluids and medications&lt;br /&gt;
*'''Discharge with close follow-up:'''&lt;br /&gt;
**Mild-moderate hypokalemia corrected with oral supplementation&lt;br /&gt;
**Tolerating PO fluids and home medications&lt;br /&gt;
**Stable hemodynamics&lt;br /&gt;
**Pediatric nephrology follow-up within days&lt;br /&gt;
*'''New diagnosis suspected''' (unexplained hypokalemic metabolic alkalosis in a young patient with renal potassium/chloride wasting and normal BP): arrange '''nephrology referral''' for confirmatory workup&lt;br /&gt;
*'''Counsel families:''' aggressive oral hydration is critical (especially during illness, hot weather, exercise); report symptoms of hypokalemia (weakness, cramps, palpitations, fainting) immediately&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Gitelman syndrome]]&lt;br /&gt;
*[[Hypokalemia]]&lt;br /&gt;
*[[Metabolic alkalosis]]&lt;br /&gt;
*[[Nephrolithiasis]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK442019/ StatPearls — Bartter Syndrome]&lt;br /&gt;
*[https://www.kidney-international.org/article/S0085-2538(20)31404-6/fulltext Kidney Int — Diagnosis and management of Bartter syndrome: ERKNet consensus (2021)]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC6233707/ PMC — Bartter syndrome: causes, diagnosis, and treatment (2018)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Renal]]&lt;br /&gt;
[[Category:Pediatrics]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>